GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Ergo Science Corp (GREY:ERGN) » Definitions » Net Current Asset Value

Ergo Science (Ergo Science) Net Current Asset Value : $-4,800.00 (As of Sep. 2006)


View and export this data going back to . Start your Free Trial

What is Ergo Science Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Ergo Science's net current asset value per share for the quarter that ended in Sep. 2006 was $-4,800.00.

The historical rank and industry rank for Ergo Science's Net Current Asset Value or its related term are showing as below:

ERGN's Price-to-Net-Current-Asset-Value is not ranked *
in the Business Services industry.
Industry Median: 4.235
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Ergo Science Net Current Asset Value Historical Data

The historical data trend for Ergo Science's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ergo Science Net Current Asset Value Chart

Ergo Science Annual Data
Trend Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28,987.32 28,169.01 31,608.45 -49,711.27 -2,175.86

Ergo Science Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,773.24 -2,175.86 -1,003.45 -5,677.59 -4,800.00

Competitive Comparison of Ergo Science's Net Current Asset Value

For the Staffing & Employment Services subindustry, Ergo Science's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ergo Science's Price-to-Net-Current-Asset-Value Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Ergo Science's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Ergo Science's Price-to-Net-Current-Asset-Value falls into.



Ergo Science Net Current Asset Value Calculation

Ergo Science's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2005 is calculated as

Net Current Asset Value Per Share(A: Dec. 2005 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(13.656-10.611-0-4.307)/0.00058
=-2,175.86

Ergo Science's Net Current Asset Value (NCAV) per share for the quarter that ended in Sep. 2006 is calculated as

Net Current Asset Value Per Share(Q: Sep. 2006 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(13.132-11.609-0-4.307)/0.00058
=-4,800.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ergo Science  (GREY:ERGN) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Ergo Science Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Ergo Science's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Ergo Science (Ergo Science) Business Description

Traded in Other Exchanges
N/A
Address
402 Office Park Drive, Suite 260, Birmingham, AL, USA, 35223
Ergo Science Corp is a United States based workforce injury prevention and treatment provider. It is focused on employee safety and employer risk reduction. The company offers physical abilities tests built from defensible, peer-reviewed research; evidence-based injury prevention and rehabilitation for diversified businesses.
Executives
Citigroup Inc director 388 GREENWICH STREET, NEW YORK NY 10013
Iticorp director 399 PARK AVENUE, NEW YORK NY 10043
Citicorp Banking Corp director ONE PENNS WAY, NEW CASTLE DE 19720
Citigroup Holdings Co director 336 THE STRAND, LONDON ENGLAND
Court Square Capital Ltd director 399 PARK AVE, NEW YORK NY 10043

Ergo Science (Ergo Science) Headlines

No Headlines